BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12493542)

  • 1. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F; Laznicek M; Laznickova A
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
    Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
    Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
    Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A
    Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
    Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
    Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
    Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
    J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH.
    Kanazawa T; Shimizu M; Seto H; Kageyama M; Kameda K; Toyoshima S; Tomizawa G; Watanabe N; Inagaki S
    Nucl Med Commun; 1998 Sep; 19(9):899-903. PubMed ID: 10581597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
    Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
    J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
    Eshima D; Taylor A
    Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous technetium-99 MAG(3), iodine-131-orthoiodohippurate and iodine-125 iothalamate clearance and biodistribution after bolus injection in rats.
    Casadevall G; Turull A; Piera C; Queralt J
    Biopharm Drug Dispos; 2000 Jul; 21(5):181-92. PubMed ID: 11180197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats.
    Pathuri G; Sahoo K; Awasthi V; Gali H
    Nucl Med Commun; 2011 Oct; 32(10):908-12. PubMed ID: 21876402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
    Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
    Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
    Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
    Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A; Eshima D; Christian PE; Milton W
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.